Wake-promoting agents (eugeroics)
- Promote wakefulness without classic amp profile
- Modafinil/armodafinil are prototypes
- Narcolepsy, shift-work disorder, OSA sleepiness
- Less euphorigenic than amphetamine stimulants
- Headache, insomnia + rash
- Modafinil induces CYP3A and inhibits CYP2C19
- Does not replace treatment of sleep apnea
Class at a glance
- Promote wakefulness without classic amp profile
Members / distinctions
- Modafinil/armodafinil are prototypes
- Less euphorigenic than amphetamine stimulants
Pharmacology
- Modafinil induces CYP3A and inhibits CYP2C19
Clinical role
- Narcolepsy, shift-work disorder, OSA sleepiness
- Does not replace treatment of sleep apnea
Safety / monitoring
- Headache, insomnia + rash
Self-check
- Does a wake-promoting drug replace sleep-apnea treatment?
No. - Which CYP enzymes does modafinil induce and inhibit?
Induces CYP3A; inhibits CYP2C19.
Drugs in this class (4)
All drug classes · Open Wake-promoting agents (eugeroics) in the interactive console ↗